Psychiatry & Neurology Doctors in Creve Coeur, MO Accepting Medicare

7 Psychiatry & Neurology doctors found. Showing 1 - 7

Howard Ivan Weiss, M.D. Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 456 N New Ballas Rd, Suite 324, Creve Coeur, MO 63141 Phone: 314-569-3381    Fax: 314-569-1383

Saad Z Khan, M.D. Psychiatry & Neurology - Psychiatry Medicare: May Accept Medicare Assignments Practice Location: 777 Craig Rd Ste 130, Creve Coeur, MO 63141 Phone: 314-872-7792    Fax: 314-872-5655

Dr. Laishang Peter Zhang, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 777 Craig Rd, Suite 200, Creve Coeur, MO 63141 Phone: 314-991-2500    Fax: 314-991-2504

Dr. Arturo Calvo Taca Jr., MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 11477 Olde Cabin Rd, Suite 210, Creve Coeur, MO 63141 Phone: 314-997-5208    Fax: 314-997-5368

Dr. Robin S Park, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 777 Craig Rd, Suite 100, Creve Coeur, MO 63141 Phone: 314-991-1033    Fax: 314-991-1031

Dr. Vivek Agnihotri, M.D. Psychiatry & Neurology - Addiction Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 12401 Olive Blvd Ste 100, Creve Coeur, MO 63141 Phone: 314-627-1399    Fax: 314-380-2417

Sunna Khan, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 777 Craig Rd Ste 130, Creve Coeur, MO 63141 Phone: 314-872-7792    Fax: 314-872-5655

News Archive

Scientists discover M3-protein can help maintain blood sugar levels

Medical scientists at the University of Leicester have identified for the first time a new way in which our body controls the levels of sugar in our blood following a meal.

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

Celgene International Sàrl today announced that results from a study evaluating the combination of REVLIMID (lenalidomide) plus VIDAZA (azacitidine) in patients 60 years or older with untreated acute myeloid leukemia (AML) were presented at the American Society of Hematology annual meeting in Atlanta, GA.

VeriChip to commence Phase II development of an in vivo glucose-sensing RFID microchip

VeriChip Corporation and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN chemistry platform can be applied to the development of selective binding products, announced today that VeriChip plans to fund its existing development partnership with RECEPTORS to launch Phase II development of an in vivo glucose-sensing RFID microchip.

British man with HIV becomes second person ever to enter remission

A man in Britain has become the second person in the world to be cleared of HIV after receiving a stem cell transplant from an HIV-resistant donor.

Marital transitions can increase risk of large weight gain in men, women

Both marriage and divorce can act as "weight shocks," leading people to add a few extra pounds - especially among those over age 30 - according to a new study.

Read more Medical News

› Verified 2 days ago